Skip to content
TrustList
Ysios Capital logo
Venture capital firm

Ysios Capital

Life sciences investor financing biotech companies developing new therapies in Europe and the United States

Ysios Capital cover

About Ysios Capital

Ysios Capital is a life sciences investor that finances biotechnology ventures working on new medicines. It looks for companies tackling conditions where patients have few treatment options.

Products and services

  • Biotech investment: funding for companies developing new therapies.
  • Scientific and financial expertise: an international team with scientific, financial and entrepreneurial backgrounds.
  • Long-term backing: early investment that has followed some companies through mergers and acquisitions.

Clients

The firm's portfolio is a mix of biotech companies based in Europe and the United States. Examples described on its site include a bleeding-prevention protein developer, a gene therapy company for rare diseases, an antibody-drug conjugate cancer developer, an HIV vaccine company and a nanotechnology cancer company.

Key facts

  • Focus: life sciences and therapeutics
  • Regions: Europe and the United States
  • Early investment: Cellerix, founded in 2004, later merged with Tigenix and acquired by Takeda in 2018

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

As of 2026-10-08. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to Ysios Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Ysios Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Ysios Capital.

Ysios Capital alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Startup accelerator and early-stage investor running intensive batches for new technology founders

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups